Switch to:
More From Other Websites
Research Report Initiated on Select Biotechnology Equities Jun 24 2016
REPROS THERAPEUTICS INC. Files SEC form 8-K, Regulation FD Disclosure Jun 07 2016
6 Biotechs Seriously on the Move Jun 02 2016
REPROS THERAPEUTICS INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and... Jun 01 2016
Repros Provides Update on EU Submission of Enclomiphene for the Treatment of Secondary Hypogonadism... Jun 01 2016
Repros Provides Update on EU Submission of Enclomiphene for the Treatment of Secondary Hypogonadism... Jun 01 2016
REPROS THERAPEUTICS INC. Financials May 19 2016
REPROS THERAPEUTICS INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and... May 18 2016
Repros Reports Positive Clinical Data for Oral Proellex® in Women With Severe Menstrual Bleeding... May 18 2016
REPROS THERAPEUTICS INC. Files SEC form 8-K, Change in Directors or Principal Officers May 16 2016
Repros Announces the Appointment of Mr. Patrick Fourteau as Chairman of the Board May 16 2016
Repros Announces the Appointment of Mr. Patrick Fourteau as Chairman of the Board May 16 2016
Repros (RPRX) Q1 Loss Narrower Y/Y, Pipeline in Focus May 11 2016
Repros Therapeutics Inc.® Reports First Quarter 2016 Financial Results May 10 2016
Repros Therapeutics reports 1Q loss May 10 2016
Repros Therapeutics reports 1Q loss May 10 2016
REPROS THERAPEUTICS INC. Files SEC form 8-K, Results of Operations and Financial Condition,... May 10 2016
Repros Therapeutics Inc.® Reports First Quarter 2016 Financial Results May 10 2016
Will Repros Therapeutics (RPRX) Continue to Surge Higher? May 04 2016
Repros (RPRX) Q1 Earnings: What's in Store for the Stock? May 03 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK